Healio

FDA approves Johnson & Johnson’s Tecnis PureSee IOL

The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...
Healio

Deferred IOL implantation leads to better outcomes in traumatic pediatric cataract

Primary IOL implantation in pediatric open globe injuries with active inflammation showed inferior visual outcomes compared ...
MassDevice

Johnson & Johnson wins FDA nod for new intraocular lens

Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients ...
The Huntsville Item

Alcon Surpasses 175 Million IOLs Implanted Globally

This significant milestone includes more than 6 million of Alcon’s latest-generation of presbyopia-correcting IOLs (PCIOLs) that have been implanted globally, helping patients attain greater visual ...